ARC-186

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameARC-186
Drug Alias Nameunpegylated aptamer/C5a inhibitor (Ophthotech)ARC-186
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionComplement system proteins inhibitorsC5a anaphylatoxin chemotactic receptor antagonists
TargetsC5a anaphylatoxin chemotactic receptorComplement system proteins
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArchemix Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIveric Bio Inc
Active IndicationsN/A
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A